Douradinha Bruno, Reis Viviane C B, Rogers Matthew B, Torres Fernando A G, Evans Jared D, Marques Ernesto T A
Fondazione Ri.MED; Palermo, Italy; University of Pittsburgh Center for Vaccine Research; Pittsburgh, PA USA.
Centro de Biotecnologia Molecular; Instituto de Ciências Biológicas; Universidade de Brasília; Brasília, Brazil.
Bioengineered. 2014 Jan-Feb;5(1):21-9. doi: 10.4161/bioe.26271. Epub 2013 Sep 5.
Saccharomyces boulardii (S. boulardii) is a probiotic yeast related to Saccharomyces cerevisiae (S. cerevisiae) but with distinct genetic, taxonomic and metabolic properties. S. cerevisiae has been used extensively in biotechnological applications. Currently, many strains are available, and multiple genetic tools have been developed, which allow the expression of several exogenous proteins of interest with applications in the fields of medicine, biofuels, the food industry, and scientific research, among others. Although S. boulardii has been widely studied due to its probiotic properties against several gastrointestinal tract disorders, very few studies addressed the use of this yeast as a vector for expression of foreign genes of interest with biotechnological applications. Here we show that, despite the similarity of the two yeasts, not all genetic tools used in S. cerevisiae can be applied in S. boulardii. While transformation of the latter could be obtained using a commercial kit developed for the former, consequent screening of successful transformants had to be optimized. We also show that several genes frequently used in genetic manipulation of S. cerevisiae (e.g., promoters and resistance markers) are present in S. boulardii. Sequencing revealed a high rate of homology (> 96%) between the orthologs of the two yeasts. However, we also observed some of them are not eligible to be targeted for transformation of S. boulardii. This work has important applications toward the potential of this probiotic yeast as an expression system for genes of interest.
布拉氏酵母菌(S. boulardii)是一种益生菌酵母,与酿酒酵母(S. cerevisiae)相关,但具有独特的遗传、分类学和代谢特性。酿酒酵母已广泛应用于生物技术领域。目前,有许多菌株可供使用,并且已经开发了多种遗传工具,这使得人们能够表达几种感兴趣的外源蛋白,并应用于医学、生物燃料、食品工业和科学研究等领域。尽管布拉氏酵母菌因其对多种胃肠道疾病的益生菌特性而受到广泛研究,但很少有研究探讨将这种酵母用作表达具有生物技术应用价值的外源基因的载体。在这里,我们表明,尽管这两种酵母有相似之处,但并非所有用于酿酒酵母的遗传工具都能应用于布拉氏酵母菌。虽然可以使用为酿酒酵母开发的商业试剂盒实现后者的转化,但随后对成功转化子的筛选必须进行优化。我们还表明,酿酒酵母遗传操作中常用的几个基因(如启动子和抗性标记)在布拉氏酵母菌中也存在。测序显示这两种酵母的直系同源基因之间具有很高的同源率(> 96%)。然而,我们也观察到其中一些基因不适合用于布拉氏酵母菌的转化靶向。这项工作对于这种益生菌酵母作为感兴趣基因的表达系统的潜力具有重要应用价值。